Health and life sciences news releases, as the companies issue them.
All releases
27 recent releases from TMX Newsfile, newest first, refreshed every 5 minutes. This list follows a fixed rule; nothing in it is chosen, ranked or paid for. Times are Eastern.
Hemostemix announces that President and CEO Thomas Smeenk will present today at 12:00 p.m. Eastern Time at the Small Cap Growth Virtual Investor Conference, hosted by Virtual Investor Conferences, an OTC Markets Group…
iSpecimen, an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, announced today that it will effect a reverse stock split of…
Kiora Pharmaceuticals has posted an on-demand video featuring President and CEO Brian M. Strem, Ph.D., discussing the in-licensing of KIO-401 (mitucapistat), an investigational oral calpain inhibitor for sudden vision…
Vesalius, a leading global peptide and longevity company, is pleased to announce the appointment of Dr. Peter Diamandis to its Board of Directors (the "Board"), effective November 19, 2026.Dr. Diamandis is a highly…
Marvel Biosciences Corp. and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively the "Company" or "Marvel"), announces the award of 59,693 deferred share units ("DSUs") to Marvel's three independent…
Doseology is pleased to report that all matters were approved at the Company's annual general meeting of shareholders (the "Meeting") held on November 18, 2026. A total of 2,824,597 common shares were voted…
ONE HEMP applauded U.S. Senators Tim Sheehy (R-MT) and Amy Klobuchar (D-MN) for introducing the bipartisan Hemp Guardrails Act, legislation that would replace sweeping federal hemp restrictions set to take effect on…
Telo Genomics Corp.TSXV: TELOOTCQB: TDSGFTMX Newsfile
Telo Genomics Corp., a leader in the development of diagnostic and prognostic tests based on three-dimensional analysis of telomeres (which are the ends of chromosomes), today announced that it has signed a term sheet…
Tuesday, November 17, 2026
Charlotte's Web Holdings, Inc.TSX: CWEBOTCQX: CWBHFTMX Newsfile
Charlotte's Web Holdings, Inc. today announced its strong support for the Hemp Guardrails Act, with bipartisan legislation introduced today by U.S. Senators Tim Sheehy (R-MT) and Amy Klobuchar (D-MN) that would replace…
Envoy Medical, a hearing health and neuroprosthetics company pioneering fully implanted hearing solutions, today announced it has been granted two additional patents in the United States and Hong Kong, bringing its…
Rhelion an Ontario-based organization advancing innovation and research within the legal psychedelic sector. Through its wholly owned subsidiary Filament Health Corp. ("Filament"), the…
Defence, a publicly traded biotechnology and precision intracellular drug-delivery company, is pleased to invite shareholders to its upcoming Annual General Meeting ("AGM" or the "Meeting") on December 10, 2026, in…
Highlights: Exclusive distribution arrangement in Qatar with an initial 36-month term, intended to support local registration, marketing, sale and distribution of TempraMed productsMinimum unit purchase commitment with…
Friday, November 13, 2026
Noveris Health Sciences Inc.CSE: NVRSFSE: 0NF1OTC Pink: MYCOFTMX Newsfile
Noveris Health Sciences Inc. announces that its board of directors (the "Board") has commenced a strategic review process to evaluate the strategic and financial alternatives available to the Company (the "Strategic…
Delivra Health Brands Inc.TSXV: DHBOTCQB: DHBUFTMX Newsfile
Delivra Health, hereby issues a correction to its news release dated November 11, 2026 (the "Prior Release") regarding a shares for payables settlement agreement to satisfy an aggregate of approximately $90,000 of the…
Thursday, November 12, 2026
Charlotte's Web Holdings, Inc.TSX: CWEBOTCQX: CWBHFTMX Newsfile
Charlotte's Web, a botanical wellness innovation company and a market leader in cannabidiol (CBD) hemp extract wellness products, today announced results for the quarter ended September 30, 2026. All amounts are…
Wednesday, November 11, 2026
Delivra Health Brands Inc.TSXV: DHBOTCQB: DHBUFTMX Newsfile
Delivra Health, a consumer packaged goods company uniquely positioned in the health and wellness sector, is pleased to announce it has entered into a shares for payables settlement agreement (the "Agreement"), to…
FloraWorks, a cannabinoid biotechnology company, today announced that an independent panel of scientific experts unanimously concluded its proprietary, high-purity cannabinol (CBN) ingredient, TruCBN™, is Generally…
Quinsam is announcing its Q3/2026 results, with net income of $0.1 million ($0.001 per share basic, $0.001 fully diluted) versus net income of $0.1 million ($0.001 per share basic, $0.001 fully diluted) in Q3/2025.…
Rhelion Life Sciences Corp.CSE: RHELFSE: 4YX0OTCQB: TRUFFTMX Newsfile
Rhelion an Ontario-based organization advancing innovation and research within the legal psychedelic sector. Through its wholly owned subsidiary Filament Health Corp. ("Filament"), the Company develops, manufactures and…
Psyched Wellness Ltd. (OTCID: PSYCF) (FSE: 5U9) (the "Company" or "Psyched Wellness"), a life sciences company focused on the production and distribution of Amanita Muscaria-derived health and wellness products…
Doseology announces revocation of the management cease trade order ("MCTO") previously issued on October 29, 2026; and its intention to voluntarily adopt the Semi-Annual Reporting ("SAR") Pilot Program pursuant to…
Rhelion an Ontario-based organization advancing innovation and research within the legal psychedelic sector. Through its wholly owned subsidiary Filament Health Corp. ("Filament"),…
Neural announces a change to its Board of Directors and provides updates regarding its previously announced transaction with CWE European Holdings Inc. ("CWE").Board of DirectorsThe Company announces that John Durfy has…
Rhelion, an Ontario-based organization advancing innovation and research within the legal psychedelic sector. Through its wholly owned subsidiary Filament Health Corp. ("Filament"), the Company develops, manufactures and…
Doseology, a consumer product innovation company focused on oral pouch and functional stimulant product technologies, announces that it was unable to file its annual audited financial statements, management's discussion…